Skip to content
2000
image of Current Perspectives of Diabetic Dyslipidemia and Treatment Modalities

Abstract

Introduction

Diabetes mellitus is associated with an increased risk of atherosclerosis related to dyslipidemia. Although the terms hyperlipidemia and Diabetes Mellitus (DM) or diabetic dyslipidemia are interrelated to each other, these two conditions have some differences.

Aim

This study aimed to highlight possible mechanisms of hyperlipidemia and/or dyslipidemia in diabetic patients, which can be treated with available and newer hypolipidemic drugs. We also re-checked current specific guidelines and their recommendations on the management of patients with diabetic dyslipidemia.

Methods

Comprehensive search of peer-reviewed journals was performed based on a wide range of keywords, including diabetes mellitus, dyslipidemia, hyperlipidemia, insulin resistance, free-fatty acids, cardiovascular disease, SCORE-2 calculation, statins, PCSK-9 inhibitors, and fibrates.

Discussion

Diabetic patients with dyslipidemia, including decreased HDL cholesterol, a predominance of small dense LDL particles, and increased triglyceride levels, are more prone to suffering from micro and macrovascular complications regardless of plasma fasting glucose levels. Recent guidelines suggested using the validated scoring system called SCORE2-Diabetes. Moderate to high dosages of statins, aiming for LDL cholesterol reduction, is still the cornerstone in the management of diabetic patients with dyslipidemia. Nowadays, other recommended non-statin drugs, including proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors or other novel therapeutic agents (bempedoic acid, inclisiran), are particularly important and given place in recently published guidelines.

Conclusion

The risk of developing atherosclerotic cardiovascular diseases in people with DM is relatively higher than in patients’ without DM. Optimal management of lipid parameters and achieving desired target values in lipid parameters are still a challenging issue for clinicians.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673336501241001093417
2025-01-13
2025-02-10
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0109298673336501241001093417
Loading
/content/journals/cmc/10.2174/0109298673336501241001093417
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test